(03) 9528 1910

Research

Fragile X Carrier Screening Study

Study: Informed decision making and psychosocial outcomes in pregnant and nonpregnant women offered population fragile X carrier screening

The results of this study, conducted by scientists at the Murdoch Children’s Research Institute and the University of Melbourne, are now published.

You can see details here:

The study concluded that “evidence to inform guidelines that population FXS carrier screening can be implemented with minimal psychosocial harms following appropriate information and prescreening genetic counseling”.

Fragile X Alliance Inc. president, and medical director of Genetic Clinics Australia, Dr Jonathan Cohen, a co-author of the study, is quoted in an ABC article “Fragile X: Experts say all women should be offered screening for genetic condition

He said that doing the test before a woman was pregnant gave them options.

“They can still go down that path if they wish — they can get pregnant, get tested and terminate, or not terminate, … Or they can go through IVF PGD — which is pre-implantation genetic diagnosis … That’s when an embryo is made, the embryo gets tested and only the unaffected embryo is implanted.”

Informed decision making and psychosocial outcomes in pregnant and nonpregnant women offered population fragile X carrier screening

By Murdoch Children’s Research Institute and the University of Melbourne

This study involved non-pregnant women, and women up to 13 weeks pregnant, recruited from obstetric and GP clinics.

The finding was that population screening causes minimal psychosocial harms, when accompanied by appropriate information and prescreening genetic counseling.

You can see the results in Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics and download a full pdf version.